Clinical Trial Update: Noninvasive Surrogate Marker for Advanced Hepatocellular Carcinoma Response to Concurrent Chemoradiotherapy: MR Perfusion, Contrast Enhanced Ultrasound and Biomarkers [NA]

View source ↗

Summary

This clinical trial update describes noninvasive imaging and biomarkers to monitor response to concurrent chemoradiotherapy in advanced hepatocellular carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Yonsei University | Conditions: Advanced Adult Hepatocellular Carcinoma | NA | Status: UNKNOWN